|
|
 |
|
Viewing report
|
|
|
|
The Lifestyle Drugs Outlook To 2008: Unlocking New Value In Well-Being
Business Insights, Oct 2003, Pages: 246
The lifestyle drugs market is currently worth a phenomenal $23bn to boost its value, pharmaceutical companies are actively searching for new lifestyle products and conditions. The Lifestyle Drugs Outlook to 2008: Unlocking new value in well-being, provides a timely market update, examining leading products and pipeline prospects in seven key lifestyle drug sectors, and is supported by forecasts to 2008. Today's R&D is influenced as much by commercial unmet needs as it is by clinical opportunities and chance. Pharmaceutical companies must react quickly to these needs if they are to reap greater financial returns. This report can help you to assess the premium associated with different lifestyle drug markets and identify the potential for higher volume sales. Armed with this information your company can formulate winning lifestyle drug development and marketing strategies, and secure a strong competitive position within this market.
Customers who bought this item also bought
Lifestyle Disorders Market to 2016 - Limited Pipeline Products and Slow Progress in R&D are Major Concerns
Transdermal Drug Delivery - Technologies, Markets, and Companies
The Lifestyle Drugs Outlook To 2007: Challenges And Opportunities In A High-Profile Growth Market
Alopecia Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Commercial Opportunities From An Aging Population: Epidemiology, Market And Pipeline Analysis Across Seven Major Indications
U.S. Sexual Dysfunction Medication Markets
The Women’s Health Market Outlook to 2016
Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018 - Future Therapies for Birth Control and Reproductive Health
Nicholas Hall's Lifestyle OTCs Report
R&D Trends: Women's Health - Investment needed to address lack of innovation
|
|
|
|
